Trends in the Treatment of Acute Myeloid Leukaemia in the Elderly
- 1 January 2005
- journal article
- Published by Springer Nature in Drugs & Aging
- Vol. 22 (11), 943-955
- https://doi.org/10.2165/00002512-200522110-00004
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- New agents in acute myeloid leukemia and other myeloid disordersCancer, 2004
- Gemtuzumab ozogamicin in the treatment of acute myeloid leukemiaCancer, 2003
- Measuring Complications of Cancer Treatment Using the SEER-Medicare DataMedical Care, 2002
- Long‐term follow‐up of patients ≥60 yr old with acute myeloid leukaemia treated with intensive chemotherapyEuropean Journal of Haematology, 2002
- Acute Myeloid LeukaemiaDrugs & Aging, 2002
- INTERVAL AFTER PROSTATE SPECIFIC ANTIGEN TESTING AND SUBSEQUENT RISK OF INCURABLE PROSTATE CANCERJournal of Urology, 2001
- Acute Myeloid LeukemiaNew England Journal of Medicine, 1999
- Dose intensification in acute myloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's ATML9 studyBritish Journal of Haematology, 1996
- Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at DiagnosisMedical Care, 1995
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992